期刊
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 16, 期 12, 页码 3180-3183出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2006.03.042
关键词
renieramycin G; 3-epi-renieramycin G; jorumycin; 3-epi-jorumycin; antitumor agents; tetrahydroisoquinolines
资金
- NCI NIH HHS [R01 CA085419-12, R01 CA085419-11, R01 CA085419, R01 CA085419-08, R01 CA085419-10, CA85419, CA105898, R01 CA085419-09, F32 CA105898] Funding Source: Medline
Analogues of the tetrahydroisoquinoline family of antitumor antibiotics, 3-epi-jorumycin (3) and 3-epi-renieramycin G (4), in addition to their respective parent natural products (-)-jorumycin (1) and (-)-renieramycin G (2) were evaluated against both human colon (HCT-116) and human lung (A549) cancer cell lines. (-)-Jorumycin (1) displayed potent growth inhibition with GI(50) values in the low nanomolar range (1.9-24.3 nM), while compounds 2-4 were found to be substantially less cytotoxic (GI(50) 0.6-14.0 mu M). (c) 2006 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据